NCT00129090View on ClinicalTrials.gov

Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2017

Conditions
Non-Hodgkin's Lymphoma (NHL)
Interventions
DRUG

R-CHOEP 14 with 12x Rituximab

after amendment 3 patients receive 4x 375mg/m2 in cycle 1 (day 0,1,4,8), 2x 375/m2 in cycle 2 (day1,8) and 1x 375mg/m2 cycle 3-8 (day 1 of each cycle)

Trial Locations (1)

20099

AK St. Georg, Hamburg

All Listed Sponsors
collaborator

Deutsche Krebshilfe e.V., Bonn (Germany)

OTHER

lead

German High-Grade Non-Hodgkin's Lymphoma Study Group

OTHER

NCT00129090 - Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter